SSA
PFE icon

SSA Swiss Advisors’s Pfizer PFE Stock Holding History

SSA Swiss Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.52M Hold
126,369
– – 1.63% 22
2025
Q4 		$3.16M Hold
126,369
– – 1.47% 29
2025
Q3 		$3.22M Hold
126,369
– – 1.5% 28
2025
Q2 		$3.2M Buy
126,369
+14,900
+13% +$347K 1.54% 30
2025
Q1 		$2.83M Buy
+111,469
New +$2.92M 1.45% 32

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

SSA Swiss Advisors's PFE Position: Q1 2026 in Review

SSA Swiss Advisors held its Pfizer (PFE) position steady in Q1 2026 at 126,369 shares worth $3.52M. The position accounts for 1.63% of the portfolio, ranked #22.

SSA Swiss Advisors first reported a position in PFE in Q1 2025 and has held it in 5 quarters since. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • SSA Swiss Advisors held 126,369 shares of Pfizer worth $3.52M as of Q1 2026.
  • SSA Swiss Advisors left its Pfizer share count unchanged in Q1 2026.
  • Pfizer made up 1.63% of SSA Swiss Advisors's portfolio in Q1 2026, its #22 holding.
  • SSA Swiss Advisors first reported a position in Pfizer in Q1 2025 and has held it in 5 quarters since.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on SSA Swiss Advisors's 13F filing for Q1 2026, filed 21 Jul 2026.